Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01633060 |
|---|---|
| Brief Title: | A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi (BELLE-3) |
| First Submitted : | June 29, 2012 |
| First Submitted that Met QC Criteria : | June 29, 2012 |
| First Posted : | July 4, 2012 (Estimate) |
| Results First Submitted : | September 20, 2018 |
| Results First Submitted that Met QC Criteria : | January 8, 2019 |
| Results First Posted : | January 9, 2019 |
| Last Update Submitted that Met QC Criteria : | January 9, 2019 |
| Last Update Posted : | January 30, 2019 |